WeightWatchers' New Direction: Combining Weight Loss and Obesity-Drug Business
WeightWatchers' acquisition of Sequence, a drug-prescribing business, signals a shift in the weight-loss industry as powerful new drugs like Ozempic challenge the conventional wisdom that obesity can only be addressed through lifestyle changes. The move shows that the old guard is being forced to adapt or die.